Shipounova Irina N, Petinati Nataliya A, Bigildeev Alexey E, Drize Nina J, Sorokina Tamara V, Kuzmina Larisa A, Parovichnikova Elena N, Savchenko Valeri G
a Physiology of Hematopoiesis Lab , Federal Government Budget Institution National Research Center for Hematology, Ministry of Health , Moscow , Russian Federation.
b Department of High-Dose Chemotherapy , Depressions of Hematopoiesis and Bone Marrow Transplantation, Federal Government Budget Institution National Research Center for Hematology, Ministry of Health , Moscow , Russian Federation.
Leuk Lymphoma. 2017 Feb;58(2):408-417. doi: 10.1080/10428194.2016.1187277. Epub 2016 May 31.
Bone marrow (BM) derived adult multipotent mesenchymal stromal cells (MMSCs) and fibroblast colony-forming units (CFU-Fs) of 20 patients with acute myeloid leukemia (AML) and 15 patients with acute lymphoblastic leukemia (ALL) before and during 1 year after receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT) were studied. The growth characteristics of MMSCs of all patients before allo-HSCT were not altered; however, relative expression level (REL) of some genes in MMSCs, but not in CFU-Fs, from AML and ALL patients significantly changed. After allo-HSCT, CFU-F concentration and MMSC production were significantly decreased for 1 year; REL of several genes in MMSCs and CFU-F-derived colonies were also significantly downregulated. Thus, chemotherapy that was used for induction of remission did not impair the function of stromal precursors, but gene expression levels were altered. Allo-HSCT conditioning regimens significantly damaged MMSCs and CFU-Fs, and the effect lasted for at least 1 year.
对20例急性髓系白血病(AML)患者和15例急性淋巴细胞白血病(ALL)患者在接受异基因造血干细胞移植(allo-HSCT)之前及之后1年内的骨髓(BM)来源的成人多能间充质基质细胞(MMSC)和成纤维细胞集落形成单位(CFU-F)进行了研究。所有患者在allo-HSCT之前MMSC的生长特性未改变;然而,AML和ALL患者MMSC中一些基因的相对表达水平(REL)发生了显著变化,而CFU-F中则未改变。allo-HSCT后,CFU-F浓度和MMSC产量在1年内显著降低;MMSC和CFU-F衍生集落中几个基因的REL也显著下调。因此,用于诱导缓解的化疗并未损害基质前体细胞的功能,但基因表达水平发生了改变。allo-HSCT预处理方案显著损害了MMSC和CFU-F,且这种影响持续了至少1年。